RELATED: CVS-Aetna got the green light. Brace yourselves, stakeholders say Leon saved his harsher rhetoric for the DOJ, which failed to provide information about public comments on the settlement which required Aetna to sell its Part D business to WellCare. DOJ said in its brief that "public comments would not alter [its] analysis." The judge was particularly curious about comments from American Medical Association (AMA) provided. The AMA has vehemently opposed the deal for weakening competition, as it explained in a letter to the DOJ (PDF) in August.